HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

PeopleandPicks.com is Zacks' Community Website
Find great stocks and great stock pickers in our online community. It's social, it's profitable and it's Free! Join the fun at PeopleandPicks.com
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

ELN: Elan Corp Plc - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

ELAN CORP PLC (NYSE)
ELN 6.32 -0.03 (-0.47%) Vol.  2,047,274 16:01 ET

Day Low - High 6.31 - 6.47
52wk Low - High 4.61 - 9.13
Avg Volume 6,440,508
Industry MED-DRUGS
Market Cap 3.02 B
Div - Yield 0.00 - 0.00
PE (forward)
PEG Ratio N/A
Current Year Est. -.46
EPS Last Year -0.53
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
#1 Strong Buy 26.51%
#2 Buy 16.63%
#3 Hold 7.53%
#4 Sell 2.01%
#5 Strong Sell -0.07%
S&P 500 8.70%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 11/18/2009
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
ELAN CORP PLC ELN PREMIUM
SUPERGEN INC SUPG PREMIUM
VALEANT PHARMA VRX PREMIUM
SANTARUS INC SNTS PREMIUM
See all MED-DRUGS Peers

BROKERAGE RECOMMENDATIONS
Current ABR 3.00
ABR (Last Week) 3.00
# of Recs in ABR 9
Average Target Price 6.18
Industry Rank by ABR 36 out of 217
Rank in Industry 94 out of 114
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate ELN?
Buy
Sell
Find out what the Zacks Community
thinks of ELN at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR ELN
Zacks Equity Research: Report for ELN
Nov 18, 2009
Zacks Blog: FDA Approval for Glaxo Drug
Oct 28, 2009
Zacks Blog: Zacks Analyst Blog Highlights: Biogen Idec, Elan, UnitedHealth Group Inc., Forest Laboratories, Inc. and Cypress Biosciences
Oct 21, 2009
Zacks Blog: Biogen Reports Higher Earnings
Oct 20, 2009
Zacks Blog: Zacks Bull and Bear of the Day Highlights: VimpelCom, Rite Aid Corporation, Johnson & Johnson, Elan Pharmaceuticals and Gilead Sciences, Inc.
Oct 14, 2009
More Zacks Commentary
NEWS
Elan to Present at Lazard Capital Markets Annual Healthcare Conference07000000
Nov 13, 2009
BiomedReports: News and FDA Updates for Alexion (Nasdaq:ALXN), Biogen (NASDAQ:BIIB), Elan (NYSE:ELN)
Nov 11, 2009
Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Nov 10, 2009
Elan Corp (ELN) NewsBite - ELN Could Be On the Move
Nov 10, 2009
Elan Down 5.7% Since SmarTrend's Sell Recommendation
Nov 06, 2009
More News
EARNINGS ESTIMATES
  This Quarter
12/2009
Next Quarter
03/2010
This Year
12/2009
Next Year
12/2010
Average Estimate -0.09 -0.08 -0.46 -0.20
Number of Estimates 5 2 4 6
Low Estimates -0.15 -0.09 -0.57 -0.50
High Estimate -0.06 -0.06 -0.21 0.19
Year Ago EPS -0.13 -0.22 -0.64 -0.46
EPS Growth 30.77% 65.91% 28.91% 56.41%

More Estimates

COMPANY DESCRIPTION
Elan Corporation, plc is a leading worldwide specialty pharmaceutical company focused on the discovery, development and marketing of therapeutic products and services in neurology, acute care and pain management and on the development and commercialization of products using its extensive range of proprietary drug delivery technologies. The company consists of three operating divisions: Elan Pharmaceuticals, Elan Pharmaceutical Technologies and Elan Pharmaceutical Operations.

Full Company Report
FINANCIALS
EPS TTM -.53
Sales 1000.2
Net Income 51
Price/Earnings N/A
Price/Book 5.48
Price/Cash Flow N/A
Price/Sales 2.79


More Financials

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research